InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2024-11-15 00:00:00 ET · period of report 2024-11-13 · accession 0001601830-24-000207 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-11-15 2024-11-13+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 +40.0K 782.7K +5% $0
DM 2024-11-15 2024-11-13+ RXRX Gibson Christopher CEO, Dir S - Sale $7.54 -40.0K 762.7K -5% -$301.8K
DM 2024-11-15 2024-11-13+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 -40.0K 6.08M -0.7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-11-14 C A 20,000 $0.00 782,656 D — —
2 Common Class A Common Stock 2024-11-14 S D 20,000 $7.35 762,656 D — —
3 Common Class A Common Stock 2024-11-13 C A 20,000 $0.00 782,656 D — —
4 Common Class A Common Stock 2024-11-13 S D 20,000 $7.74 762,656 D — —
5 Derivative Class B Common Stock 2024-11-14 C D 20,000 $0.00 6,056,700 D $0.00 · — to — 20,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
6 Derivative Class B Common Stock 2024-11-13 C D 20,000 $0.00 6,076,700 D $0.00 · — to — 20,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.